avoid like plague
adjusted loss
artificially boost revenue
back fire
cut position
credit crunch
competition emerge
cold hearted
caught surprise
criminal investigation
class action
decline United States
decline demand
decrease earnings
dead money
earning miss
false statements
federal prosecutors
miss earning
earning decline
decline earning
fall cliff
gone nowhere
hard hearted
high risk
increase short interest
increased operating expenditure
lawsuit
limited upside
losing money
low confidence
lower target
not exactly attractive
not attractive
massive losses
more pressure
negative publicity
negative earnings
negative effects
overpriced
overly optimistic
price gouging
price slip
pull back
pulling money
reflect badly
raised concern
rejected marketing authorization
sales decreased
sales miss
short interest
stay away
significant risk
specialty pharmacy
state budgets
unsustainable
value trap
weak pipeline
Weak Outlook
week low



